CHUV
Les activités du CHUV
MENU
Centre du sein
Accueil > Recherche > Publications > Publications 2010

Publications 2010


  1. Ambrosetti A, Fraisse T, Perey L, Delaloye JF, Brioschi PA, Zaman K, Petignat P and de Ziegler D and collaborative group.
    Cancer and Fecundity: A multidisciplinary task sets clinical guidelines for women of reproductive age affected by cancer in French-speaking Switzerland.
    Swiss Med Wkly. 2010;140:w13075.

  2. Azria D, Belkacemi Y, Romieu G, Gourgou S, Gutowski M, Zaman K, Moscardo CL, Lemanski C, Coelho M, Rosenstein B, Fenoglietto P, Crompton NE, Ozsahin M.
    Concurrent or sequential adjuvant letrozole and radiotherapy after conservative surgery for early-stage breast cancer (CO-HO-RT): a phase 2 randomised trial.
    Lancet Oncol. 2010 Mar;11(3):258-65. doi: 10.1016/S1470-2045(10)70013-9. Epub 2010 Feb 6. PubMed PMID: 20138810.

  3. Cameron DA, Marreaud S, Zaman K, Bodmer A, Pierga J, Brain E, Veyret C, Bartlett JM, Bogaerts J, Bonnefoi HR.
    LAPATAX: A randomized phase II trial of FEC-docetaxel combined with lapatinib and/or trastuzumab as neoadjuvant therapy of HER2-positive breast cancer - EORTC 10054 trial.
    2010 ASCO Annual Meeting ; Poster TPS116.

  4. Dahmane E, Mercier T, Zanolari B, Cruchon S, Guignard N, Buclin T, Leyvraz S, Zaman K, Csajka C, Decosterd LA.
    An ultra performance liquid chromatography-tandem MS assay for tamoxifen metabolites profiling in plasma: first evidence of 4'-hydroxylated metabolites in breast cancer patients.
    J Chromatogr B Analyt Technol Biomed Life Sci. 2010 Dec 15;878(32):3402-14. doi: 10.1016/j.jchromb.2010.10.027. Epub 2010 Oct 30. PubMed PMID:21094101.

  5. Delaloye JF, Capoccia Brugger R, Ifticene Treboux A, Anaye A, Meuwly JY.
    Ultrasonography-guided drainage should be considered as the first-line approach for the treatment of breast abscess.
    Rev Med Suisse. 2010 Oct 27;6(268):2010-2. French. PubMed PMID: 21137460.

  6. Fiche M, Lepori D, Guntern D, Jucker-Kupper P, Jeanneret W, Zaman K, Vadot S, Delaloye JF.
    Improving breast cancer education: the case of an evolving multidisciplinary module for undergraduate medical students (Lausanne Medical School, 1993-2008).
    J Cancer Educ. 2010 Mar;25(1):101-5. doi: 10.1007/s13187-009-0022-0. PubMed PMID: 20082176.

  7. Koeberle D, Ruhstaller T, Jost L, Pagani O, Zaman K, von Moos R, Crowe S, Thuerlimann B, on Behalf of the Swiss Group for Clinical Cancer Research (SAKK).
    Can Resistance to Trastuzumab Be Reversed by Endocrine Therapy? Results from a Proof-of-Principle Trial in Postmenopausal Patients with Hormonal Receptor (HR) Positive, HER-2 Positive Advanced Breast Cancer (SAKK 23/03).
    San Antonio Breast Cancer Symposium 8-12.12.2010; poster P3-14-16.

  8. Thierrin L, Steiger D, Zuber JP, Spertini F, Brunisholz Y, Delaloye JF.
    Severe anaphylactic shock to Patent Blue V with cardiac arrest during breast carcinoma surgery with lymphatic mapping.
    Eur J Obstet Gynecol Reprod Biol. 2008 Sep;140(1):140-1. Epub 2007 Oct 29. PubMed PMID: 18029084.

  9. Tsoutsou PG, Belkacemi Y, Gligorov J, Kuten A, Boussen H, Bese N, Koukourakis MI; Association of Radiotherapy and Oncology in the Mediterranean area (AROME).
    Optimal sequence of implied modalities in the adjuvant setting of breast cancer treatment: an update on issues to consider.
    Oncologist. 2010;15(11):1169-78. doi: 10.1634/theoncologist.2010-0187. Epub 2010 Nov 1. PubMed PMID: 21041378; PubMed Central PMCID: PMC3227907.

  10. Wagner AD, Zaman K, Peters S, Montemurro M, Leyvraz S.
    Anti-angiogenic therapies for metastatic colorectal, breast and lung cancer: benefits and risks.
    Rev Med Suisse. 2010 May 26;6(250):1070-3. PubMed PMID:20564866.

  11. Wolfer A, Wittner BS, Irimia D, Flavin RJ, Lupien M, Gunawardane RN, Meyer CA, Lightcap ES, Tamayo P, Mesirov JP, Liu XS, Shioda T, Toner M, Loda M, Brown M, Brugge JS, Ramaswamy S.
    MYC regulation of a "poor-prognosis" metastatic cancer cell state.
    Proc Natl Acad Sci U S A. 2010 Feb 23;107(8):3698-703. doi: 10.1073/pnas.0914203107. Epub 2010 Feb 4. PubMed PMID: 20133671.

  12. Yalcin-Ozuysal O, Fiche M, Guitierrez M, Wagner KU, Raffoul W, Brisken C.
    Antagonistic roles of Notch and p63 in controlling mammary epithelial cell fates.
    Cell Death Differ. 2010 Oct;17(10):1600-12. doi: 10.1038/cdd.2010.37. Epub 2010 Apr 9. PubMed PMID: 20379195.

  13. Zaman K, Dahmane E, Csajka C, Perey L, Buclin T, Bodmer A, Leyvraz S, Galmiche Rindisbacher M, Berthod G, Chin E, Decosterd L.
    Prospective Assessment of CYP2D6 by Genotyping, Phenotyping and Measurement of Tamoxifen, 4-Hydroxy-Tamoxifen and Endoxifen in Breast Cancer Patients Treated with Tamoxifen.
    San Antonio Breast Cancer Symposium 8-12.12.2010; poster PD05-09. Poster discussion.

  14. Zaman K, Rochlitz C, Ruhstaller T, Thürlimann B, Aebi S, von Moos R, Mamot C, Gabriel N, Rossier-Pansier L, Stupp R, Crowe S, Ruegg C.
    MMP9 as Predictive Factor for Response and Progression Free Survival in Breast Cancer Patients Treated with Bevacizumab and Pegylated Liposomal Doxorubicin (PLD).
    San Antonio Breast Cancer Symposium 8-12.12.2010; poster P2-16-07.

  15. Zaugg Longchamp D, Zaman K, Aebischer N.
    Cardiologic follow up of an oncologic patient.
    Rev Med Suisse. 2010 Jun 2;6(251):1133-4, 1136-9. PubMed PMID:20572357.